Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Justin Earp"'
Autor:
Xinyuan Zhang, Yuching Yang, Manuela Grimstein, Guansheng Liu, Eliford Kitabi, Jianghong Fan, Ying‐Hong Wang, Justin Earp, James L. Weaver, Hao Zhu, Jiang Liu, Kellie S. Reynolds, Shiew‐Mei Huang, Yaning Wang
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 9, Pp 973-982 (2021)
Abstract A critical step to evaluate the potential in vivo antiviral activity of a drug is to connect the in vivo exposure to its in vitro antiviral activity. The Anti–SARS‐CoV‐2 Repurposing Drug Database is a database that includes both in vit
Externí odkaz:
https://doaj.org/article/0cb77c809c824b32835bc7a4a70613b8
Autor:
Kirk Chan‐Tack, Mario Sampson, Justin Earp, Vikram Arya, Lynne Yao, John Alexander, Ethan Hausman, Yodit Belew, Debra Birnkrant, Kimberly Struble
Publikováno v:
The Journal of Clinical Pharmacology. 63:259-265
The US Food and Drug Administration is committed to the development of effective antiviral regimens for pediatric patients with coronavirus disease 2019 (COVID-19), including infants and neonates. On April 25, 2022, the approved indication of remdesi
Autor:
Richard Pazdur, R. Angelo de Claro, Brenda J. Gehrke, Jonathon Vallejo, Olanrewaju O. Okusanya, Lori A. Ehrlich, Justin Earp, Eliford Kitabi, Michael L. Manning, Haiyan Chen, Sriram Subramaniam, Kelly J. Norsworthy, Nina Kim
Supplementary Figure from FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37f9e927b0f02dd17bba71a4f750e28e
https://doi.org/10.1158/1078-0432.22486850
https://doi.org/10.1158/1078-0432.22486850
Autor:
Richard Pazdur, R. Angelo de Claro, Brenda J. Gehrke, Jonathon Vallejo, Olanrewaju O. Okusanya, Lori A. Ehrlich, Justin Earp, Eliford Kitabi, Michael L. Manning, Haiyan Chen, Sriram Subramaniam, Kelly J. Norsworthy, Nina Kim
Supplementary Table from FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6646e8ffd93f37274a5c4f534616d9
https://doi.org/10.1158/1078-0432.22486838
https://doi.org/10.1158/1078-0432.22486838
Autor:
Richard Pazdur, R. Angelo de Claro, Brenda J. Gehrke, Jonathon Vallejo, Olanrewaju O. Okusanya, Lori A. Ehrlich, Justin Earp, Eliford Kitabi, Michael L. Manning, Haiyan Chen, Sriram Subramaniam, Kelly J. Norsworthy, Nina Kim
On July 7, 2020, the Food and Drug Administration approved Inqovi (Otsuka Pharmaceutical Co.), an oral fixed-dose combination tablet comprising 35 mg decitabine, a hypomethylating agent, and 100 mg cedazuridine, a cytidine deaminase inhibitor (abbrev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b2657fe9db7acdd8a1b08385f0f4c14
https://doi.org/10.1158/1078-0432.c.6532403.v1
https://doi.org/10.1158/1078-0432.c.6532403.v1
Autor:
Nina Kim, Kelly J. Norsworthy, Sriram Subramaniam, Haiyan Chen, Michael L. Manning, Eliford Kitabi, Justin Earp, Lori A. Ehrlich, Olanrewaju O. Okusanya, Jonathon Vallejo, Brenda J. Gehrke, R. Angelo de Claro, Richard Pazdur
Publikováno v:
Clin Cancer Res
On July 7, 2020, the Food and Drug Administration approved Inqovi (Otsuka Pharmaceutical Co.), an oral fixed-dose combination tablet comprising 35 mg decitabine, a hypomethylating agent, and 100 mg cedazuridine, a cytidine deaminase inhibitor (abbrev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89cb8f049331b0d3b0c1fa1e112223a3
https://europepmc.org/articles/PMC9378483/
https://europepmc.org/articles/PMC9378483/
Publikováno v:
Blood. 124:4016-4016
Erythropoiesis-stimulating agents (ESAs) reduce transfusion use in patients with anemia of CKD (A-CKD) but ESA use is associated with worse cardiovascular outcomes in all trials to date. Several studies indicate that patients with A-CKD who have init
Autor:
Justin Earp
Publikováno v:
Pharmaceutical Research; Jan2009, Vol. 26 Issue 1, p196-203, 8p
Publikováno v:
Journal of Pharmacokinetics & Pharmacodynamics; Oct2004, Vol. 31 Issue 5, p345-380, 36p